Skip to main content

Tower Research Capital LLC (TRC)

Position in ADCT — ADC Therapeutics SA

CIK 1533421 NEW YORK, NY

Position in ADCT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$29,970
+$15,868 QoQ
Shares Held
7,992
+100.1% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Tower Research Capital LLC (TRC) holds $6,284,154 across 59 Drug Manufacturers - Specialty & Generic names. ADCT ranks #31 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ADCT

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $29,970 7,992
2025-12-31 $14,102 3,995
2025-09-30 $22,436 5,609
2025-06-30 $34,247 12,779
2025-03-31 $14,288 10,134
2024-12-31 $11,138 5,597
2024-09-30 $14,634 4,646
2023-12-31 $24,304 14,641
2023-09-30 $3,695 4,120
2023-06-30 $12,300 5,721
2023-03-31 $122 63
2022-12-31 $11,270 2,935
2022-09-30 $45,659 9,473
2022-06-30 $5,565 700
2022-03-31 $10,826 737
2021-12-31 $44,217 2,189
2021-09-30 $1,222 45
2021-03-31 $2,001 82
2020-12-31 $147,341 4,603